This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Universität Zu Koln. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Simon Poll-Wolbeck: Innovator in Neoplastic Disease Treatment
Introduction
Simon Poll-Wolbeck is a notable inventor based in Cologne, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of neoplastic diseases. His innovative work focuses on developing compounds that can effectively combat various types of cancers.
Latest Patents
Simon Poll-Wolbeck holds a patent for "Compounds useful in the treatment of neoplastic diseases." This patent includes compounds and pharmaceutically acceptable salts that are beneficial in treating neoplastic diseases or proliferative disorders. The compounds are formulated into pharmaceutical compositions that can be utilized in methods of treating cancers such as prostate, pancreatic, lung, skin, breast, bladder, colon, and blood cancers.
Career Highlights
Poll-Wolbeck's career is marked by his dedication to advancing cancer treatment. His research has led to the development of innovative compounds that offer new hope for patients suffering from various forms of cancer. He is affiliated with the Universität zu Köln, where he continues to contribute to the scientific community.
Collaborations
Throughout his career, Simon Poll-Wolbeck has collaborated with esteemed colleagues, including Albrecht Berkessel and Mark Krüger. These partnerships have fostered a collaborative environment that enhances research and innovation in the field of cancer treatment.
Conclusion
In summary, Simon Poll-Wolbeck is a pioneering inventor whose work in developing compounds for the treatment of neoplastic diseases has the potential to make a significant impact on cancer therapy. His contributions to medicine are invaluable and continue to inspire future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
